Colgate-Palmolive (NYSE:CL) Shares Sold by Toronto Dominion Bank

Toronto Dominion Bank lessened its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 12.0% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 454,840 shares of the company’s stock after selling 62,008 shares during the quarter. Toronto Dominion Bank’s holdings in Colgate-Palmolive were worth $44,138,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Main Street Research LLC boosted its position in Colgate-Palmolive by 1.5% in the 2nd quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after buying an additional 100 shares during the last quarter. Advisor OS LLC lifted its stake in shares of Colgate-Palmolive by 4.5% in the second quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after acquiring an additional 101 shares in the last quarter. BLB&B Advisors LLC boosted its holdings in Colgate-Palmolive by 2.5% in the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after purchasing an additional 104 shares during the last quarter. ZWJ Investment Counsel Inc. grew its stake in Colgate-Palmolive by 3.1% during the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock valued at $349,000 after purchasing an additional 109 shares in the last quarter. Finally, Hexagon Capital Partners LLC increased its holdings in Colgate-Palmolive by 9.5% during the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock worth $124,000 after purchasing an additional 110 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on CL shares. Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price target for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. BNP Paribas began coverage on shares of Colgate-Palmolive in a research report on Monday, June 24th. They issued an “outperform” rating and a $109.00 target price for the company. Wells Fargo & Company cut shares of Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price target on the stock. in a research report on Monday, September 16th. UBS Group upped their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Evercore ISI lifted their target price on Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research report on Thursday, July 18th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $104.74.

Read Our Latest Stock Analysis on Colgate-Palmolive

Insider Buying and Selling

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock valued at $4,486,063 over the last quarter. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Down 0.0 %

Shares of Colgate-Palmolive stock opened at $103.76 on Thursday. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $109.30. The company has a market capitalization of $85.13 billion, a P/E ratio of 32.84, a PEG ratio of 3.62 and a beta of 0.40. The business’s fifty day moving average price is $102.96 and its two-hundred day moving average price is $96.10. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.77 earnings per share. As a group, research analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.93%. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.